DyerD.G., DunnJ.A., ThorpeS.R., BailieK.E., LyonsT.J., McCanceD.R., BaynesJ.W.Accumulation of Maillard reaction products in skin collagen in diabetes and Aging. J Clin Invest1993; 91: 2463–9.
2.
OdettiP., ForgartyJ., SellD.R., MonnierV.M.Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes1992; 41: 153–9.
3.
MakitaZ., RadoffS., RayfieldE.J., YangZ., SkolnikE., DelaneyV., FriedmanE.A.Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med1991; 325: 836–42.
4.
SellD.R., MonnierV.M.Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem1989; 264: 21597–602.
5.
AhmedM.U., ThorpeS.R., BaynesJ.W.Identification of Nε-(carboxymethil)lysine as a degradation product of fructoselysine in glycated protein. J Biol Chem1986; 261: 4889–94.
6.
MiyataT., UedaY., ShinzatoT.Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol1996; 7: 1198–206.
7.
DegenhardtT.P., GrassL., ReddyS., ThorpeS.R., DiamandisE.P., BaynesJ.W.The serumconcentration of the advanced glycation end-product Nε-(carboxymethyl)lysine is increased in uremia. Kidney Int1997; 52: 1064–7.
8.
MiyataT., WadaY., CaiZ.Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int1997; 51: 1170–81.
9.
FuM.X., RequenaJ.R., JenkinsA.J., LyonsT.J., BaynesJ.W., ThorpeS.R.The advanced glycation end product, Nε-(carboxymethyl)lysine, is a product of lipid peroxidation and glycoxidation reactions. J Biol Chem1996; 271: 9982–6.
10.
OdettiP., GaribaldiS., GurreriG., AragnoI., DapinoD., PronzatoM.A.Protein oxidation in hemodialysis and kidney transplantation. Metabolism Clinical and Experimental1996; 45: 1319–22.
11.
KumanoK., YokotaS., GoM., SuyamaK., SakaiT., EraS., SogamiM.Quantitative and qualitative changes of serum albumin in CAPD patients. Adv Perit Dial1992; 8: 127–30.
12.
Wtko-SarsatV., FriedlanderM., Capeillere-BlandinC.Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int1996; 49: 1304–13.
13.
MiyataT., MaedaK., KurokawaK., van Ypersele de StrihouC.Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dial Transplant1997; 12: 255–8.
14.
Wells-KnechtK.J., ZyzakD.V., LitchfieldJ.E., ThorpeS.R., BaynesJ.W.Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of protein by glucose. Biochemistry1995; 34: 3702–9.
15.
AhmedM.A., FryeE.B., ThorpeS.R., BaynesJ.W.Nε-(carboxymethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J1997; 324: 565–70.
16.
GlombM.A., MonnierV.M.Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem1995; 276: 10017–25.
17.
EsterbauerH., SchuerR.J., ZollnerH.Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehyde. Free Radic Biol Med1991; 11: 81–128.
18.
MiyataT., van Ypersele de StrihouC., KurokawaK., BaynesJ.W.Alterations in non-enzymatic biochemistry in uremia: origin and significance of “carbonyl stress” in long-term uremic complications. Kidney Int (in press)
19.
MiyataT., JadaulM., KurokawaK., van Ypersele de StrihouC.ß2-microglobulin in renal disease. J Am Soc Nephrol (in press)
20.
MiyataT., OdaO., InagiR.ß2–Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest1993; 92: 1243–52.
21.
MiyataT., TanedaS., KawaiR.Identification of pentosidine as a native structure for advanced glycation end products in ß2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA1996; 93: 2353–8.
22.
MiyataT., HoriO., ZhangJ.H., YanS.D., FerranL., IidaY., SchmidtA.M.The receptor for advanced glycation end products mediates the interaction of AGE- ß2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: implication for the pathogenesis of dialysis-related amyloidosis. J Clin Invest1996; 98: 1088–94.
23.
MiyataT., InagiR., IidaY.Involvement of ß2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1. J Clin Invest1994; 93: 521–8.
24.
MiyataT., IidaY., UedaY.Monocyte/macrophage response to ß2-microglobulin modified with the advanced glycation end products. Kidney Int1996; 49: 538–50.
25.
MiyataT., NotoyaK., YoshidaK., HorieK., KurokawaK., MaedaK., TaketomiS.Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol1997; 8: 260–70.
